Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Selective cannabinoid-1 receptor blockade benefits fatty acid and triglyceride metabolism significantly in weight-stable nonhuman primates.

Vaidyanathan V, Bastarrachea RA, Higgins PB, Voruganti VS, Kamath S, DiPatrizio NV, Piomelli D, Comuzzie AG, Parks EJ.

Am J Physiol Endocrinol Metab. 2012 Sep 1;303(5):E624-34. doi: 10.1152/ajpendo.00072.2012. Epub 2012 Jul 3.

2.

[Rimonabant (Acomplia), specific inhibitor of the endocannabinoid system].

Ducobu J, Sternon J.

J Pharm Belg. 2005;60(3):89-91. Review. French.

PMID:
16252510
3.

The endocannabinoid system as a novel approach for managing obesity.

Lillo JL.

J Am Osteopath Assoc. 2007 Apr;107(4 Suppl 2):S12-20. Review.

PMID:
17784530
4.

The endocannabinoid system and the control of glucose homeostasis.

Nogueiras R, Rohner-Jeanrenaud F, Woods SC, Tschöp MH.

J Neuroendocrinol. 2008 May;20 Suppl 1:147-51. doi: 10.1111/j.1365-2826.2008.01692.x. Review.

PMID:
18426514

Supplemental Content

Support Center